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Abstract 
 
 
Background: 
 
Vitamin E highly-crosslinked polyethylene (HXLPE) was developed to reduce wear in 
total hip replacement (THR). This formal systematic review and meta-analysis aimed 
to provide independent synthesis of wear characteristics of Vitamin E treated HXLPE 
compared to HXPLE/UHMWPE. Secondary outcome measures were differences in 
revision rates and functional scores. 
 
 
Methods: 
 
We performed a formal systematic review as per PRISMA guidelines; literature 
searches were conducted on 14th November 2017 (MEDLINE, Embase on Ovid, and 
the Cochrane Library). We included randomized controlled trials, analyses of joint 
registries, and case-controlled studies of primary THR comparing cups with a Vitamin 
E HXLPE bearing with bearing surfaces made from other types of polyethylene. Initial 
screening was performed by two independent assessors; disagreement resolved in 
discussion with a third reviewer. Studies were evaluated using the Cochrane risk of 
bias tool. Data extraction permitted meta-analysis. 
 
 
Results: 
 
372 studies were identified on initial screening, 5 studies met the eligibility criteria. 
There was no significant heterogeneity between studies. There was variable risk of bias. 
At a mean of 35 months (range 20 to 60), Vitamin E HXLPE had significant advantages 
over highly crosslinked polyethylene with regards total femoral head penetration 
(p=0.004). Given the RSA measurement errors this may not be clinically significant. 
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There were neither significant differences in revision rates nor Harris Hip Scores 
(p=0.06). 
 
 
Conclusion: 
 
At a minimum of three years follow-up there was reduced total femoral head 
penetration for Vitamin E HXLPE over HXLPE. This bearing surface does not as yet 
have clinically significant advantages in terms of revision rates or patient function over 
HXLPE. 
 
 
Keywords: 
 
Vitamin E, Meta-analysis, Total hip replacement 
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Introduction: 
 
Ultra-high molecular weight polyethylene (UHMWPE) has been in used for nearly 60 
years yet historically many other bearing materials have been tried [1, 2]. According 
to National Joint Registry of England and Wales (NJR) UHMWPE is used in 88% of 
THR’s [3]. Wear mediated aseptic loosening is a common cause of revision in THR 
[3]. UHMWPE wear by oxidative degradation decreases wear resistance and leads to 
increased osteolysis; a major cause of implant failure [1,3-6]. 
 
 
The sterilisation process is a major contributor to UHMWPE degradation [7,8]. High-
energy radiation, used in sterilisation processes, induces oxidation. Bond scission 
occurs with the formation of free radicals [2]. This reduces molecular mass and alters 
the mechanical properties of the UHMWPE. The oxidation continues during storage 
and in vivo once implanted [9]. In 1998, highly-crosslinked and thermally treated 
polyethylenes (HXLPEs) were introduced to improve wear resistance. It was theorized 
they would reduce the incidence of revision. Crosslinking results in an increased 
molecular mass; improving wear resistance and mechanical properties compared to 
UHMWPE [10,11]. Following irradiation, the HXLPEs are thermally treated to remove 
residual free radicals. Two different processes, remelting and annealing, are used. Only 
remelting treatment effectively removes residual free radicals [12,13]. Other processing 
methods have been considered but have not been able to eradicate free radicals meaning 
oxidative degradation can occur [14]. 
 
 
Vitamin E (VE) is an antioxidant that can be added to the HXLPEs to combat oxidative 
degradation and improve fatigue properties by avoiding post-irradiation melting [15]. 
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In vitro studies have demonstrated a protective effect of VE on oxidative degradation, 
with improved mechanical and wear properties [16-18]. Additionally, in vitro and 
animal studies have not demonstrated adverse reactions [19]. Despite this, there is 
currently limited clinical evidence to support the use of Vitamin E HXLPE. 
 
 
There are two methods of adding Vitamin E: the first is by blending UHMWPE powder 
with vitamin E prior to consolidation and cross-linking (blended Vitamin E HXLPE); 
the second is by doping the consolidated and cross-linked material in a hot Vitamin E 
solution, allowing vitamin E to diffuse into the material (diffused Vitamin E HXLPE) 
[20]. The purpose of this study is to provide an independent synthesis of the wear 
characteristics of Vitamin E treated HXLPE compared to HXPLE or UHMWPE. 
Secondary outcome measures were differences in revision rates and functional scores. 
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Materials and Methods: 
 
Before commencing the review, the study protocol was registered with PROSPERO 
(CRD42017074141) as recommended by the Quality of Reporting of Meta-analyses 
(QUOROM) statement [21]. We used a rigorous and systematic approach conforming 
to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 
and a PRISMA checklist is included in Appendix 1. 
 
 
Search strategy 
 
We searched the electronic databases MEDLINE and Embase on the OVID platform, 
and The Cochrane Library using the search strategy shown in Figure 1. Searches were 
conducted from database inception to 15th November 2017. We did not limit the search 
to English language publications. We also evaluated the grey literature with hand 
searches of conference abstracts published in 6 major Orthopaedic journals in the 5 
years before the search date. Bibliographies of relevant articles were checked and key 
citations tracked in Web of Science. 
 
 
Eligibility criteria 
 
We included all randomized controlled trials (RCT’s), analyses of joint registries and 
case-controlled studies including patients of all age groups receiving primary total hip 
replacement using Vitamin E HXLPE compared to any other type of polyethylene. 
 
 
Screening 
 
Title and abstracts were screened by two independent assessors with any disagreements 
resolved in discussion with a third reviewer. If any uncertainties relating to inclusion 
occurred we planned to contact authors for clarification. 
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Data extraction 
 
Two of the authors worked independently to extract the data using standardized forms. 
We extracted data on: study country; recruitment dates; setting; participant 
characteristics; duration of follow-up; acetabular and femoral head bearing material and 
size; outcomes relating to primarily the degree and measurement of femoral head 
penetration; secondarily the revision rates, Harris Hip Score, patient reported outcome 
measures; and risk of bias. An electronic spreadsheet was constructed to summarise the 
findings of relevant studies. 
 
 
Study quality 
 
Potential sources of bias in RCTs were assessed using the Cochrane risk of bias tool 
[22]. This method assesses selection, performance, detection, attrition, and reporting 
biases. Summary assessments of risk-of-bias (high, low or unclear) for each outcome 
in each trial are reported. We planned to use alternative risk of bias assessment methods 
for assessment of non-randomised studies. 
 
 
Statistical analysis 
 
Data was combined in meta-analysis using Review Manager software (Review 
Manager (RevMan) 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane 
Collaboration; 2014). Heterogeneity was assessed using the I2 statistic representing the 
proportion of variability across studies not due to chance or random error. Pre-specified 
subgroup analysis was performed relating to different polyethylene comparators and 
femoral head materials. 
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Results: 
 
A total of 372 records were identified by literature searches. The titles and abstracts 
were screened to identify potentially useful articles for inclusion. After screening, 16 
articles were assessed for eligibility. A flow diagram of the progression of studies 
through the systematic review is provided in Figure 2. 
 
 
There were 5 articles that contributed to our estimates of femoral head penetration, 
revision and functional outcome. There were 4 prospective randomised controlled trials 
(RCT’s), all from Europe with recruitment from 2008, of which 3 examined diffused 
Vitamin E HXLPE compared to HXLPE [23-25]. The remaining RCT compared 
Vitamin E blended HXLPE to conventional UHMWPE [26]. Study characteristics are 
summarized in Table 1. There was a low risk of bias amongst RCT’s when we examined 
sequence generation, allocation/concealment, blinding, completedness of data and 
reporting (Table 2). One other study from Japan had a case-control design and 
compared blended Vitamin E HXLPE and HXLPE. Although the authors reported 
propensity matching we considered the study to be at high risk of bias because under a 
quarter of the 348 patients recruited were followed up [20]. 
 
 
Vitamin E HXLPE compared to HXLPE 
 
All RCT’s used radiostereometry (RSA) to examine femoral head penetration. In 2 
studies with 187 patients followed up for 2 and 5 years [23,27], total reported femoral 
head penetration was presented. In the meta-analysis shown in Figure 3, total reported 
femoral head penetration was significantly less in the Vitamin E diffused HXLPE 
groups compared with conventional HXLPE, mean difference 0.08mm (95%CI 0.13, 
0.02; p=0.004) and no heterogeneity was evident (Figure 3). However the RSA 
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measurement errors in these two studies were 0.13mm and 0.14mm respectively 
therefore this numerically significant difference is unlikely to be clinically significant. 
Furthermore only one study was at low risk of bias [23] and in this study with 51 
patients followed up, the difference between groups was not statistically significant 
(p=0.09). In one case-control study there was no difference between patients in femoral 
head penetration between Vitamin E blended HXLPE and HXLPE liners (p=0.161) but 
risk of bias was high due to the reporting of interim follow up of 24% of patients [20]. 
 
 
Meta-analyses of femoral head penetration by vector are shown in Figures 4-6. 
Transverse femoral head penetration was reported in 2 RCTs with data from 104 
patients followed up for 2 [23] and 5 years [28]. In the meta-analysis shown in Figure 
4, transverse femoral head penetration was lower in patients receiving a Vitamin E 
diffused HXLPE liner, mean difference 0.08mm (95%CI 0.03, 0.14; p=0.003) with no 
heterogeneity evident. In the one study at low risk of bias [23], the difference was 
statistically significant (p=0.004). 
 
 
Three RCTs with 167 patients followed up for 2 [23] or 5 years [28] [27] reported 
vertical femoral head penetration. In the meta-analysis shown in Figure 5, vertical head 
penetration was lower in patients receiving a Vitamin E diffused HXLPE liner, mean 
difference 0.10mm (95%CI 0.07, 0.14; p<0.00001) and there was no heterogeneity 
between studies. In the one study with low risk of bias [23], the difference was 
statistically significant, p=0.035. 
 
 
Two RCTs with 104 patients followed up reported anteroposterior femoral head 
penetration at 2 and 5 years [23,28]. The meta-analysis in Figure 6 showed a high level 
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of heterogeneity between the studies, I2=56% and we only show the results for 
completeness. One study showed a trend favouring the group who received a Vitamin 
E diffused HXLPE liner [28] and the other a trend favouring the control group receiving 
HXLPE [23]. Neither trend was statistically significant and only the latter study was at 
low risk of bias. 
 
 
Revision rates 
 
Study sample sizes were small and revision rates low. Overall there were 3 revisions in 
the Vitamin E diffused group and 5 revisions in the control HXLPE group. Two 
revisions for dislocations occurred in patients receiving Vitamin E diffused HXLPE 
and 1 in control patients receiving HXLPE but all were in a study with unclear risk of 
bias due to uneven losses to follow up between groups at 5 years [28]. In the case 
control study with high risk of bias, there was 1 disclocation in patients receiving 
blended vitamin E HXLPE liners compared with 2 in those receiving an HXLPE liner. 
 
 
 
 
Patient reported outcomes 
 
Two RCTs with 104 patients and data suitable for meta-analysis reported the Harris 
Hip Score at 2 years [23] and 5 years [28] follow up. As shown in Figure 7, 
heterogeneity between studies was high. One study with low risk of bias showed no 
statistically significant difference between groups at 2 years (p=0.295). One RCT with 
data suitable for meta-analysis [28] and another only reporting medians and ranges [27] 
had unclear risk of bias due to uneven loss to follow up. In neither was there a 
statistically significant difference in Harris Hip Score between groups. 
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In two RCTs, patient reported health related quality of life was assessed using the EQ- 
5D [23,28]. There were no differences between outcomes in either study, including one 
at low risk of bias [23]. 
 
 
Vitamin E blended HXLPE compared to UHMWPE 
 
In one RCT with 100 patients randomised and follwed up for 3 years, vitamin E blended 
HXLPE liners were compared with UHMWPE liners [26]. Total head penetration was 
lower in the vitamin E HXLPE group (p=0.04) but the study was at unclear risk of bias 
due to high losses to follow up. There was no difference in functional outcome 
measured using the Merle d’Aubigné score (p>0.99). 
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Discussion: 
 
Total hip replacement is a clinically effective and cost-effective intervention [29]. Any 
improvement in the outcome of THR is likely to arise through reducing the incidence 
of adverse events or reducing the need for subsequent revision surgery. This formal 
systematic review and meta-analysis has shown that Vitamin E HXLPE has reduced 
femoral head penetration over highly-crosslinked and conventional polyethylenes. 
However the differences are small in comparison to the measurement error of the 
techniques used to measure it and there is no evidence from our rigorous systematic 
review to show a clinically significant benefit of Vitamin E HXLPE over HXLPE in 
terms of revision rate or function at this early stage. The lack of difference in functional 
scores is perhaps not surprising as Harris Hip Score is a score to assess the effect of 
THR as an intervention and not to tell the difference between patients undergoing 
THR with different types of bearing surface. Ceramic-on-HXLPE in primary total hip 
replacement has been shown to have the lowest all-cause revision rates in a large 
national joint registry study [30] and the reduced wear evident with the use of Vitamin 
E HXLPE may lead to further reduction in revision rates. A reduction in revision rates 
has not been shown in this study. 
 
 
The findings of our study should be interpreted with caution. A recent high quality 
systematic review and network meta-analysis of 3177 THR’s concluded that there was 
currently insufficient evidence to recommend any bearing combination over a 
traditional metal on UHMWPE THR [31]. However a prospective RCT of 122 patients 
at 10 years follow-up not included in this systematic review and network meta-analysis 
showed that HXLPE liners have a significantly reduced wear and greater survival rate 
compared to UHMWPE liners [32]. Furthermore although in vitro evidence has shown 
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increased bacterial resistance with Vitamin E HXLPE [33], there was no evidence in 
our study to support a decreased rate of revision for periprosthetic infection with this 
bearing surface. 
 
 
Systematic review and meta-analysis with assessment of risk of bias can help clinicians 
to interpret results of studies in diverse settings with different outcome measures. There 
are limitation to this study however. There are a limited number of randomized 
controlled trials all of limited follow-up from which to extract data and there were only 
187 patients contributing to the meta-analysis of total femoral head penetration. Further 
RCT’s examining Vitamin E HXLPE are underway however [34,35]. We did not 
perform a network meta-analysis to compare blended and diffused Vitamin E HXLPE 
especially given the high risk of bias determined in the only study that examined the 
latter. There were a variety of femoral head sizes used in the studies and both metal 
and ceramic femoral heads were included. However we extracted data using rigorous 
selection criteria and there was low heterogeneity for total femoral head penetration. 
Furthermore this study could not account for precise cup positioning, patient activity, 
Body Mass Index and whether the requisite hip biomechanics were restored in the 
cases used; such factors we acknowledge can affect wear rates. 
 
 
Long–term follow-up, high-quality independent RCT’s involving large numbers of 
patients and using consistent outcome reporting or large generalisable observational 
cohorts with comprehensive coverage are required to determine if lower wear results in 
lower revision rates. Such studies should be undertaken however before guidance can 
be provided on clinical effectiveness of new technologies in THR. 
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Conclusions: 
 
This systematic review and meta-analysis showed that there were numerically but not 
clinically significant wear advantages in terms of femoral head penetration for Vitamin 
E HXLPE over HXLPE. There was no improvement in revision rates or functional 
outcome at this stage. However there were few high quality studies and longer-term 
follow-up is required. This bearing surface has encouraging early results in terms of 
wear. 
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Tables: 
 
Table 1. Study characteristics 
Study 
Country 
Baseline 
dates 
Setting 
Inclusion 
Number 
randomised: 
intervention; 
control 
Mean age (SD) 
% female 
Groups compared 
Common treatments 
Key 
outcomes 
Longest 
follow up 
Overall risk of bias 
Key results 
 
 
RCTs: Vit E diffused HXLPE vs HXLPE 
Salemyr et al. 
2015 [23] 
Sweden 
2009-2013 
1 hospital 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nebergall et 
al 2017 [28] 
Denmark 
2009-2011 
1 hospital 
Primary OA 
51: 25: 26 (24; 
26 received 
allocated 
intervention) 
62 (6); 62 (5) 
58%; 56% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary OA 
82: 41; 41 (32; 
35 received 
allocated 
intervention) 
Median (range) 
67 (43, 76); 65 
(40, 73) 
50%; 54% 
Vit E diffused HXLPE 
liner (E1, Biomet) 
vs standard HXLPE 
liner (Marathon, 
Depuy) 
Uncemented 
acetabular shell. 
Uncemented stem with 
32mm cobalt chrome 
head 
  
 
 
 
 
 
 
 
 
 
 
 
 
Vit E diffused HXLPE 
liner (E1, Biomet) vs 
medium cross- linked 
PE liner (ArcomXL, 
Biomet) 
Uncemented 
acetabular shell. 
Uncemented stem with 
32mm ceramic head 
Radiography, 
RSA, HHS, 
EQ-5D, 
complications 
24 months 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Radiography, 
RSA, HHS, 
PROMs, 
osteolysis 
5 years 
Low risk of bias 
Included in meta- 
analysis 
Head penetration in 
transverse x (p=0.004) 
and vertical y 
(p=0.035) axes were 
lower in Vit E group. 
Similar in 
anteroposterior z axis 
(p=0.629). Total 
penetration similar 
between groups 
(p=0.09). 
Revisions: 1; 1 
HHS (p=0.295) and 
EQ-5D (p=0.173) 
similar between 
groups. Overall 
number of 
complications similar 
between groups. 
Unclear risk of bias 
due to uneven loss to 
follow up at 5 years (4; 
9) 
Included in meta- 
analysis 
Head penetration in 
mediolateral x, 
proximodistal y and 
anteroposterior z axes 
similar between 
groups. 
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Shareghi et al. 
2017 [27] 
Sweden 
2008-2010 
1 hospital 
 
 
 
 
 
 
 
 
Osteoarthritis 
61 (70 hips): 38; 
32 hips 
Median (range) 
58 (20, 73) 
 
 
 
 
 
 
 
 
Vit E diffused HXLPE 
liner (E1, Biomet) vs 
heat-treated HXLPE 
(ArComXL, Biomet) 
Uncemented 
acetabular shell. 
Uncemented stem with 
32mm CoCr head 
 
 
 
 
 
 
 
 
Radiography, 
RSA, HHS 
(self- 
reported), 
pain score 
5 years 
Revisions: 2; 3 
No differences 
between groups in 
HHS, UCLA activity, 
SF-36 physical 
function, EQ-5D, VAS 
pain and satisfaction. 
No osteolysis observed 
Unclear risk of bias 
due to uneven loss to 
follow up (1; 6) and 
randomisation method 
Included in meta- 
analysis 
Total head penetration 
and head penetration in 
proximal y axis lower 
in Vit E group than 
heat treated group 
(p=0.004 and p<0.001 
respectively). 
Revisions: 0; 1 
No difference in HSS 
between groups 
(p=0.90) or pain score 
(p=0.80). 
 
 
RCT: Vit E blended HXLPE vs UHMWPE 
Scemama et 
al. 2017 [26] 
France 
2010-2011 
1 hospital 
Primary or 
secondary OA 
100 (50; 50) 
Median (range) 
67 (32, 74); 66 
(49, 75) 
48%; 56% 
Vit E blended HXLPE 
(Vitamys, Mathys) vs 
UHMWPE (Mathys) 
Monoblock cementless 
acetabular component. 
Cemented stem with 
28mm CoCr head 
Radiography, 
Martell, 
Merle 
d’Aubigné 
grade, 
adverse 
events 
3 years 
Unclear risk of bias 
due to high losses to 
follow up (13; 11). 
No suitable data for 
meta-analysis 
Total head penetration 
lower in Vit E HXLPE 
group compared with 
UHMWPE (p=0.04). 
No differences 
between groups in 
Merle d’Aubigné grade 
(p>0.99). No adverse 
events related to Vit E 
HXLPE 
 
 
Case control study: Vit E blended HXLPE vs HXLPE 
Tanino et al. 
2017 [20] 
Japan 
170; 178 (180; 
193 hips). 44; 41 
(45; 45 hips) 
followed up 
Blended Vit E HXLPE 
liner vs conventional 
HXLPE liner 
32mm CoCr head 
Radiography, 
2 years 
High risk of bias. 
Propensity matched 
but only partial 
follow up 
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2013-2015 
1 centre 
61.1 (range 42, 
89) 
Sex not reported 
No differences 
between femoral head 
penetration 
(p=0.161). 
Dislocation 1; 2. 
Infection 1; 0. 
 
 
 
Table 2. RCT risk of bias assessment 
 
 Sequence Allocation Blinding of Incomplete Selective Other sources Overall 
generation concealment participants, outcome outcome of bias  
  personnel data reporting   
  and outcome     
  assessors     
Salemyr Low. Block Low. Low. Low. 1 Low. Low. HHS Low 
et al. randomisation Opaque Patients patient did None higher in Vit  
2015 [23]  sealed blinded not receive apparent E HXLPE  
  envelopes  vit E  group but not  
    HXLPE as  significantly  
    allocated.    
    1;1    
    patients    
    died    
Nebergall Low. Pre- Low. Sealed Low. Unclear. Low. Low. Vit E Unclear 
et al 2017 assigned envelopes “Blinded” Uneven None group older  
[28]    loss to apparent than  
    follow up  comparison  
    at 5 years  group  
    (4; 9)    
Shareghi Unclear. Low. Unclear. Unclear. Low. Low Unclear 
et al. Unequal Closed Blinding of Uneven None   
2017 [27] distribution of envelopes patients and loss to apparent   
 patients to  outcome follow up    
 groups due to  assessment at 5 years    
 method of  not (1; 6)    
 allocating  described     
 bilateral       
 replacements       
Scemama Low. Low. Based Low. High. Loss Low. Low. Similar Unclear 
et al. Computer on order of Radiography to follow None baseline  
2017 [26] generated presentation by blinded up apparent characteristics  
   observer. excluding    
   High. 2 deaths    
   Clinical high (13;    
   follow up by 11)    
   operating     
   surgeon     
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Tanino et 
al. 2017 
[20] 
Propensity 
matched case 
control study 
Not 
applicable 
 High loss 
to follow 
up 
 High: partial 
follow up 
High 
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